AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Stem cell biotech stock11/20/2023 Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Food Science and BioAgriculture, and more. Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. This year's program attracted more than 1,500 nominations from over 12 different countries. The mission of the annual BioTech Breakthrough Awards program is to conduct the industry's most comprehensive analysis and evaluation of the top companies, solutions and products in the life sciences and biotechnology industry today. "We're thrilled to see our efforts to advance durable, cost-effective and scalable medicines recognized by BioTech Breakthrough, and are honored to have been selected as ‘Overall Cell Biology Company of the Year.'" "Garuda is working tirelessly to bring our off-the-shelf durable blood stem cell and immune cell programs to millions of patients in need of curative treatments," said Dhvanit Shah, Ph.D., Co-Founder and CEO of Garuda. As the industry's first off-the-shelf offering, Garuda's unique technology for generating self-renewing blood stem cells provides the company with the ability to manufacture at scale and provide potentially curative therapies for more than 120 diseases, at a fraction of the cost. Garuda earned the BioTech Breakthrough Award for the company's efforts to create off-the-shelf, hematopoietic stem cell (HSC) therapies with the aim of eliminating the dependency on donor or patient cells for blood stem cell transplants entirely. 08, 2023 (GLOBE NEWSWIRE) - BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe, today announced that Garuda Therapeutics (Garuda), a company creating off-the-shelf, durable blood stem cell-based cellular therapies, has been selected as "Overall Cell Biology Company of the Year" in the third annual BioTech Breakthrough Awards program.
0 Comments
Read More
Leave a Reply. |